Wagener, R., Kleinheinz, K., & Hübschmann, D. (2018). IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. Blood, 132(21), . https://doi.org/10.1182/blood-2018-03-842088
Chicago Style (17th ed.) CitationWagener, Rabea, Kortine Kleinheinz, and Daniel Hübschmann. "IG-MYC+ Neoplasms with Precursor B-cell Phenotype Are Molecularly Distinct from Burkitt Lymphomas." Blood 132, no. 21 (2018). https://doi.org/10.1182/blood-2018-03-842088.
MLA (9th ed.) CitationWagener, Rabea, et al. "IG-MYC+ Neoplasms with Precursor B-cell Phenotype Are Molecularly Distinct from Burkitt Lymphomas." Blood, vol. 132, no. 21, 2018, https://doi.org/10.1182/blood-2018-03-842088.
Warning: These citations may not always be 100% accurate.